When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Pharma inks deal for patient-specific ex-U.S. distribution of Gvoke
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals (XERS-6.4%) enters into a non-exclusive agreement with unlicensed medicine distributor Clinigen Group plc for the supply and distribution of Gvoke (glucagon injection) outside of the U.S. on a "named patient" basis while its marketing application in Europe is under review.
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news,